CD24 is a mucin-like cell surface glycoprotein expressed in stem/progenitor cells and a variety of human malignancies, including hepatocellular carcinoma, breast cancer, renal cell carcinoma, colon cancer, B-cell lymphoma, differentiating neuroblasts, small cell and non-small cell lung carcinoma, and nasopharyngeal carcinoma. This evidence concerns the gene CD24 and hepatocellular carcinoma.